Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 15/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 14/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 14/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 14/20 | 0.54 |
| ▸ | TACR2 | P21452 | 1/20 | 0.48 |
| ▸ | TACR1 | P25103 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6230281 | 0.87 | OPRL1 (0.50) | OPRL1OPRM1OPRD1OPRK1TACR2 | |
| Hydrochloric Acid SCHEMBL9317770 | 0.85 | CYP2D6 (0.52) | OPRL1OPRM1OPRD1OPRK1TACR2 | |
| SCHEMBL6231996 | 0.85 | OPRL1 (0.57) | OPRL1OPRM1OPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL6208233 | 0.83 | TACR2 (0.50) | OPRL1OPRM1OPRD1OPRK1TACR2 | |
| SCHEMBL6227593 | 0.83 | OPRL1 (0.56) | OPRL1OPRM1OPRD1OPRK1TACR2 | |
| Hydrochloric Acid SCHEMBL6229648 | 0.81 | TACR1 (0.52) | OPRL1OPRM1OPRD1OPRK1TACR2 | |
| Hydrochloric Acid SCHEMBL9317762 | 0.80 | TACR2 (0.65) | OPRL1OPRM1TACR2TACR1 | |
| SCHEMBL8972501 | 0.78 | TACR2 (0.51) | TACR2TACR1 | |
| SCHEMBL8050584 | 0.78 | TACR2 (0.71) | TACR2TACR1 | |
| SCHEMBL6231530 | 0.78 | SLC6A3 (0.48) | SLC6A2SLC6A4SLC6A3KCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0709375-B1 | Therapeutic heterocycles | ASTRAZENECA AB (SE) | 2005-05-18 | — | — | EP | disclosed |
| US-6147083-A | NOVEL SUBSTITUTED 1,2-ETHANEDIAMINE DERIVATIVES WHICH ANTAGONIZE THE PHARMACOLOGICAL ACTIONS OF THE ENDOGENOUS NEUROPEPTIDE TACHYKININS KNOWN AS NEUROKININS, USEFUL FOR THE TREATMENT OF ASTHMA, ETC. | ZENECA LIMITED (GB) | 2000-11-14 | — | — | US | disclosed |
| US-5998444-A | ANTIASTHMA AGENTS; NEUROKININ ANTAGONIST | ZENECA LTD. (GB) | 1999-12-07 | — | — | US | disclosed |
| US-5710169-A | NEUROKININ ANTAGONISTS; ANTIHISTAMINES, BRONCHODILATOR AGENTS; ASTHMA | ZENECA LIMITED (GB) | 1998-01-20 | — | — | US | disclosed |
| EP-0709375-A2 | Therapeutic heterocycles | ZENECA LIMITED (GB) | 1996-05-01 | — | — | EP | disclosed |